Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Stent thrombosis--risk assessment and prevention Motovska Z; Knot J; Widimsky PCardiovasc Ther 2010[Oct]; 28 (5): e92-100The development and use of stents has made percutaneous coronary intervention an effective (less restenosis), safe (treatment of emergency vessel closure during balloon angioplasty), and applicable (stents were developed for lesions of tortuous anatomy and complex situations) revascularization method. These features have firmly established stenting as first-line therapy in coronary revascularization. This life-saving device carries, however, the risk of a life-threatening complication--stent thrombosis. The article summarizes the facts about the incidence, histopathology, and risk factors of bare-metal as well as drug-eluting stent thrombosis. Future directions in reducing the incidence of stent thrombosis are also outlined.|*Stents[MESH]|Angioplasty, Balloon, Coronary/*adverse effects/*instrumentation[MESH]|Animals[MESH]|Coronary Artery Disease/*therapy[MESH]|Drug-Eluting Stents[MESH]|Fibrinolytic Agents/therapeutic use[MESH]|Humans[MESH]|Metals[MESH]|Platelet Aggregation Inhibitors/therapeutic use[MESH]|Prosthesis Design[MESH]|Risk Assessment[MESH]|Risk Factors[MESH]|Thrombosis/etiology/pathology/*prevention & control[MESH]|Treatment Outcome[MESH] |
